A director at Ultralife Corp bought 53,900 shares at 4.971USD and the significance rating of the trade was 50/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly...
Ultralife Corporation Reports Third Quarter Results NEWARK, N.Y., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) reported operating results for the third quarter ended September 30, 2025 with the following results: Sales of $43.4 million increased 21.5% from $35.7 million for the third quarter of 2024; excluding Electrochem, sales of $36.6 million increased 2.5%Gross profit of $9.6 million, or 22.2% of revenue, compared to $8.7 million, or 24.3% of revenue, for the third quarter of 2024Operating loss of $1.0 million, reflecting one-time non-recurring costs of $1.1...
Ultralife Corporation to Report Third Quarter Results on November 18, 2025 NEWARK, N.Y., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) will report its third quarter results for the period ended September 30, 2025 before the market opens on Tuesday, November 18, 2025. Ultralife’s Management will also host an investor conference call and simultaneous webcast at 8:30 AM ET on November 18, 2025. Please see the call-in procedures which follow below. NOTE TO THOSE PLANNING TO PARTICIPATE BY PHONE: To ensure a fast and reliable connection to our investor conferenc...
Ultralife Corporation Files Form 12b-25 Notification of Late Filing NEWARK, N.Y., Nov. 07, 2025 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) today announced that it has filed a Form 12b-25, Notification of Late Filing, with the Securities and Exchange Commission in connection with its Form 10-Q for the third quarter ended September 30, 2025. As previously disclosed, on October 31, 2024, Ultralife completed its acquisition of all outstanding shares of Electrochem Solutions, Inc. (“Electrochem”) from Integer Holdings Corporation (“Integer”). During the third quarter of 2025, th...
Ultralife Corporation Receives Award for Its BA-5390 Military Batteries from U.S. Defense Logistics Agency NEWARK, N.Y., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) has received an award valued at approximately $5.2 million from the U.S. Government’s Defense Logistics Agency (“DLA”) for its lithium manganese dioxide, non-rechargeable BA-5390 military batteries. The majority of the shipments are scheduled throughout 2026 with completion in early 2027. “Ultralife has been a long-standing supplier to the U.S. military, and our BA-5390 battery remains recognized f...
Ultralife Corporation Reports Second Quarter Results NEWARK, N.Y., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) reported operating results for the second quarter ended June 30, 2025 with the following results: Sales of $48.6 million increased 13.0% from $43.0 million for the second quarter of 2024; excluding Electrochem, sales of $39.3 million declined 8.7% due to a 57.2% decrease in Communications Systems salesGross profit of $11.6 million, or 23.9% of revenue, compared to $11.6 million, or 26.9% of revenue, for the second quarter of 2024Operating income of $2....
Ultralife Corporation to Report Second Quarter Results on August 7, 2025 NEWARK, N.Y., July 29, 2025 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) will report its second quarter results for the period ended June 30, 2025 before the market opens on Thursday, August 7, 2025. Ultralife’s Management will also host an investor conference call and simultaneous webcast at Noon ET on August 7, 2025. Please see the call-in procedures which follow below. NOTE TO THOSE PLANNING TO PARTICIPATE BY PHONE: To ensure a fast and reliable connection to our investor conference call, we r...
Ultralife Corporation Reports First Quarter Results NEWARK, N.Y., May 09, 2025 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) reported operating results for the first quarter ended March 31, 2025 with the following highlights: Sales of $50.7 million compared to $41.9 million for the 2024 first quarter, including a 32.4% increase for Batteries & Energy Products and a 36.2% decrease in Communications Systems salesGross profit of $12.7 million, or 25.1% of revenue, compared to $11.5 million, or 27.4% of revenue, for the 2024 first quarterOperating income of $3.4 million, including...
Ultralife Corporation to Report First Quarter Results on May 9, 2025 NEWARK, N.Y., April 29, 2025 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) will report its first quarter results for the period ended March 31, 2025 before the market opens on Friday, May 9, 2025. Ultralife’s Management will also host an investor conference call and simultaneous webcast at 10:00 AM ET on May 9, 2025. Please see the call-in procedures which follow below. NOTE TO THOSE PLANNING TO PARTICIPATE BY PHONE: To ensure a fast and reliable connection to our investor conference call, we require partic...
Ultralife Corporation Reports Fourth Quarter Results Acquisition of Electrochem Completed and Integration Has Commenced NEWARK, N.Y., April 01, 2025 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) reported operating results for the fourth quarter and full year ended December 31, 2024 as follows: Fourth Quarter: Sales of $43.9 million compared to $44.5 million for the 2023 fourth quarter, including a 11.7% increase in Battery & Energy Products sales and a 55.1% decrease in Communications Systems salesGross profit of $10.6 million, or 24.2% of revenue, co...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.